Clinical Trials Directory

Trials / Completed

CompletedNCT01655316

Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Tehran University of Medical Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

PSVT is a common rhythm disorder in emergency department which can be recurrent in some cases. Intravenous Adenosine is the drug of choice in PSVT control in acute settings but is a very short acting agent. Providing a complementary medication to decrease the rate of recurrence of PSVT after its initial control will be promising. This study evaluates the role of the oral Verapamil in recurrence control of PSVT in emergency situations.

Conditions

Interventions

TypeNameDescription
DRUGVerapamil

Timeline

Start date
2010-10-01
Primary completion
2011-08-01
Completion
2011-08-01
First posted
2012-08-01
Last updated
2012-11-14

Source: ClinicalTrials.gov record NCT01655316. Inclusion in this directory is not an endorsement.

Oral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence Control (NCT01655316) · Clinical Trials Directory